drugset / Trial / NCT01018680

A Study Comparing Duloxetine Versus Placebo in Patients Taking a Nonsteroidal Anti-inflammatory Drug (NSAID) for Knee Pain Due to Osteoarthritis

NCT01018680 ↗

Phase 3 Completed 524 enrolled Eli Lilly and Company
RandomizedParallel-groupDouble-blindTreatment

Summary

The study will test the hypothesis that, in patients with knee pain due to osteoarthritis (OA) who are taking nonsteroidal anti-inflammatory drugs (NSAIDs) but still have significant knee pain, duloxetine 60 to 120 milligrams (mg) daily for 10 weeks will provide additional reduction in pain.

Timeline

Start
2009-11
Primary completion
2011-04
Completion
2011-04

Outcome

Met primary endpoint

paper Duloxetine-treated patients had significantly greater pain reduction at week 8 (p < 0.001) than placebo-treated patients. PMID 22017192 ↗

registry LEAST_SQUARES_MEAN Placebo: -1.55 (Standard Error 0.11) units on a scale NCT01018680 ↗

registry LEAST_SQUARES_MEAN Duloxetine: -2.46 (Standard Error 0.11) units on a scale NCT01018680 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Duloxetine Small molecule 60 mg Oral
Subject Duloxetine Small molecule 120 mg Oral

Indications